INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Why Asia Should Be Your Next Trial Destination
Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic.
-
cGMP Compliant Pharmacy
See how experienced compounding support helps ensure study drugs are prepared accurately and consistently across administration routes, meeting cGMP requirements while supporting clinical protocols.
-
Who's In Charge? How To Ensure Effective Trial Oversight, Leadership
Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.
-
Analyzing 1,000+ Study Startup Records For Recruitment Performance
This overview highlights real research programs at various stages of the recruitment process and demonstrates the impact of Advarra’s Longboat Platform across multiple therapeutic areas and sponsors.
-
Uncovering The Root Cause Of Clinical Trial Troubles12/10/2024
Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
-
Metabolic Disorders Clinical Trial Case Study9/17/2024
Check out this case study to learn how partnering with an accomplished contract research organization is essential in the complex and dynamic field of metabolic drug development.
-
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies8/29/2025
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
-
Open-Label Study Assessing Relative And Absolute Bioavailability1/26/2026
Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.
-
CDA Strategies That Unclog The Study Startup Bottleneck5/8/2026
Confidential disclosure agreements (CDAs) can cause clinical trial delays, but streamlining negotiations reduces friction and improves efficiency, fostering better long-term relationships between sponsors and sites.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.
-
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.
-
Learn more about the Global ESG Program and how the continued development of sustainability initiatives contributes to positive impact on the environment and the communities in which we operate.
-
Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.